ALX ONCOLOGY HOLDINGS INC (ALXO) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $16.37M | -6.8% |
| 2024 | $17.57M | -21.6% |
| 2023 | $22.41M | -54.1% |
| 2022 | $48.82M | -86.6% |
| 2021 | $363.67M | -16.2% |
| 2020 | $434.22M | +4715.6% |
| 2019 | $9.02M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $16.37M | -6.8% |
| 2024 | $17.57M | -21.6% |
| 2023 | $22.41M | -54.1% |
| 2022 | $48.82M | -86.6% |
| 2021 | $363.67M | -16.2% |
| 2020 | $434.22M | +4715.6% |
| 2019 | $9.02M | — |